Prognostic significance of O 6-methylguanine DNA methyltransferase and p57 methylation in patients with diffuse large B-cell lymphomas

APMIS

Volumn 117, Issue 2, 2009, Pages 87-94

  Lee, Sun Mi ^b   Lee, Eui Jin ^a   Ko, Young Hyeh ^a   Lee, Sug Hyung ^b   Maeng, Leeso ^b   Kim, Kyoung Mee ^a  

^a Sungkyunkwan University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

B cell; Lymphomas; Methylation; MGMT; P57; Prognosis

Indexed keywords

CASPASE 8; CYCLIN DEPENDENT KINASE INHIBITOR 1C; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUTATHIONE TRANSFERASE P1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PREDNISONE; PROTEIN MAD2; TARGET OF METHYLATION INDUCED SILENCING 1 PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VINCRISTINE; CDKN1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE FREE SURVIVAL; DISEASE MARKER; DNA METHYLATION; DRUG RESPONSE; FOLLOW UP; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; MULTIPLE CYCLE TREATMENT; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SURVIVAL RATE; SURVIVAL TIME; GENETICS; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CPG ISLANDS; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DNA METHYLATION; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; PROGNOSIS; PROMOTER REGIONS, GENETIC;

EID: 60349085564     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00017.x     Document Type: Article

References (29)

1. Jaffe ES, Harris NL, Stein H Vardiman JW. editors. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. Ann Oncol 2002 13 : 490 1.
2. Laird PW. Cancer epigenetics. Hum Mol Genet 2005 14 (Spec No. 1) : R65 76.
3. Esteller M, Corn PG, Baylin SB Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001 61 : 3225 9.
4. Robertson KD. DNA methylation, methyltransferases, and cancer. Oncogene 2001 20 : 3139 55.
5. Santini V, Kantarjian HM Issa JP. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann Intern Med 2001 134 : 573 86.
6. Singal R Ginder GD. DNA methylation. Blood 1999 93 : 4059 70.
7. Shiozawa E, Takimoto M Makino R, et al. Hypermethylation of CpG islands in p16 as a prognostic factor for diffuse large B-cell lymphoma in a high-risk group. Leuk Res 2006 30 : 859 67.
8. Baylin SB, Herman JG, Graff JR, Vertino PM Issa JP. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998 72 : 141 96.
9. Kamb A, Gruis NA Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994 264 : 436 40.
10. Lee MH, Reynisdottir I Massague J. Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995 9 : 639 49.
11. Min KO, Seo EJ Kwon HJ, et al. Methylation of p16(INK4A) and p57(KIP2) are involved in the development and progression of gastric MALT lymphomas. Mod Pathol 2006 19 : 141 8.
12. Townsend DM Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003 22 : 7369 75.
13. Nakamichi I, Tomita Y Zhang B, et al. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma. Ann Hematol 2007 86 : 557 64.
14. Esteller M, Gaidano G Goodman SN, et al. Hypermethylation of the DNA repair gene O(6)-methylguanine DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma. J Natl Cancer Inst 2002 94 : 26 32.
15. Ohno T, Hiraga J Ohashi H, et al. Loss of O6-methylguanine-DNA methyltransferase protein expression is a favorable prognostic marker in diffuse large B-cell lymphoma. Int J Hematol 2006 83 : 341 7.
16. Pegg AE. Repair of O(6)-alkylguanine by alkyltransferases. Mutat Res 2000 462 : 83 100.
17. Cai Y, Wu MH, Ludeman SM, Grdina DJ ME. Dolan Role of O6-alkylguanine-DNA alkyltransferase in protecting against cyclophosphamide-induced toxicity and mutagenicity. Cancer Res 1999 59 : 3059 63.
18. Mattern J, Eichhorn U, Kaina B Volm M. O6-methylguanine-DNA methyltransferase activity and sensitivity to cyclophosphamide and cisplatin in human lung tumor xenografts. Int J Cancer 1998 77 : 919 22.
19. Jones PA Laird PW. Cancer epigenetics comes of age. Nat Genet 1999 21 : 163 7.
20. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 1994 368 : 753 6.
21. Drexler HG. Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 1998 12 : 845 59.
22. Otsuki T, Clark HM, Wellmann A, Jaffe ES Raffeld M. Involvement of CDKN2 (p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas. Cancer Res 1995 55 : 1436 40.
23. Al-Kuraya K, Narayanappa R Siraj AK, et al. High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle East. Hum Pathol 2006 37 : 742 8.
24. Rossi D, Capello D Gloghini A, et al. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 2004 89 : 154 64.
25. Esteller M, Risques RA Toyota M, et al. Promoter hypermethylation of the DNA repair gene O(6)-methylguanine-DNA methyltransferase is associated with the presence of G:C to A: T transition mutations in p53 in human colorectal tumorigenesis. Cancer Res 2001 61 : 4689 92.
26. Li Y, Nagai H Ohno T, et al. Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood 2002 100 : 2572 7.
27. Shen L, Toyota M Kondo Y, et al. Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia. Blood 2003 101 : 4131 6.
28. Martinez R, Schackert G Esteller M. Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme. J Neurooncol 2007 82 : 133 9.
29. Jeong SJ, Shin HJ Kim SJ, et al. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis. Cancer Res 2004 64 : 8666 73.